Trial Profile
Prospective, Non-randomized, Single-center Observational Study of Outcome Measures of Patients Suffering From Mixed Urinary Incontinence Before and After Surgical Procedure With Botulinum Toxin and Polyacrylamide Hydrogel (PAHG)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Mixed incontinence; Urinary incontinence
- Focus Therapeutic Use
- 11 Mar 2020 Status changed from recruiting to completed.
- 08 Sep 2016 Status changed from not yet recruiting to recruiting.
- 08 Jul 2016 New trial record